Only 1 in 3 U.S. Men Get Pre-Biopsy Prostate MRIs Despite 2020 Guidelines
Updated
Updated · STAT · Aug 5
Only 1 in 3 U.S. Men Get Pre-Biopsy Prostate MRIs Despite 2020 Guidelines
1 articles · Updated · STAT · Aug 5
Summary
About one-third of U.S. prostate biopsies in 2022 were preceded by MRI, even though U.S. guidelines have recommended pre-biopsy scans since 2020 and other countries already treat them as standard care.
MRI can spare 30% to 50% of men from biopsy and better target those who still need one, reducing detection of low-grade tumors that often never become dangerous.
That matters because more than 333,000 U.S. prostate cancer cases are diagnosed each year, up to 70% are low grade, and many men with clinically insignificant disease still undergo treatment.
Experts cited uneven MRI access, weak physician training in reading scans, variable image quality, and financial incentives tied to office-based biopsies as key reasons adoption remains low.
The broader debate has shifted from whether MRI should come first to how far doctors should rely on it, with U.S. specialists still split over adding systematic biopsies after MRI-targeted ones.
Why do thousands of men still undergo blind prostate biopsies when modern MRIs can safely identify who actually needs one?
Could the medical fear of missing a harmless tumor actually be causing more physical harm than prostate cancer itself?
Only 1 in 3 U.S. Men Receive Pre-Biopsy MRI: Global Standards, Insurance Reforms, and the Future of Prostate Cancer Diagnosis
Overview
Over the past decade, pre-biopsy MRI has transformed prostate cancer diagnosis by helping many patients avoid unnecessary and painful biopsies. Major medical societies now recommend MRI before biopsy, but adoption in the U.S. remains slow due to knowledge gaps among urologists, financial disincentives, and geographic disparities. Insurance reforms and value-based payment models are starting to improve access. However, significant racial and regional gaps persist, with Black patients and those in rural areas less likely to receive advanced imaging. New technologies like micro-ultrasound and AI-driven tools are emerging to bridge expertise gaps and make high-quality, less invasive diagnosis more widely available.